DCE-MRI在直肠癌分期与疗效评估中的价值:一项系统综述
该系统综述纳入19项研究,评估动态对比增强MRI(DCE-MRI)在直肠癌肿瘤侵袭性、原发分期及放化疗后再分期中的价值。半定量wash-in参数与血管生成呈显著正相关,定量分析结果矛盾;治疗前高Ktrans及放化疗后Ktrans下降32%-36%与疗效显著相关。DCE-MRI在预测和评估放化疗反应方面有前景。
要点
- 治疗前高Ktrans与完全/良好缓解显著相关,但报道的Ktrans值差异大(0.36-1.93)。
- 放化疗后Ktrans下降32%-36%与疗效显著相关。
- 半定量wash-in参数与血管生成显著正相关,定量分析结果矛盾。
核心结论
- DCE-MRI在直肠癌中主要对放化疗反应的预测和评估有前景,治疗前高Ktrans和Ktrans下降可显著预测疗效。
研究设计与样本
- 系统综述,检索Pubmed、Embase和Cochrane图书馆,纳入19项评估DCE-MRI用于肿瘤侵袭性、原发分期及放化疗后再分期的研究。
诊断标准与关键数值
- 治疗前高Ktrans与完全/良好缓解显著相关,但报道的治疗前Ktrans值差异大(0.36-1.93)。
- 放化疗后Ktrans下降32%-36%与疗效显著相关。
- 半定量分析中,治疗前晚期斜率在良好缓解者中显著更低。
- 半定量wash-in参数与血管生成呈显著正相关,而定量分析结果矛盾。
- DCE参数与肿瘤侵袭性的相关性结果矛盾:报道了更具侵袭性肿瘤中血管性更高和更低两种结果,部分研究报告无相关性。
局限性
- 定量分析结果矛盾。
- DCE参数与肿瘤侵袭性的相关性结果矛盾。
- 报道的治疗前Ktrans值差异大(0.36-1.93)。
- 放化疗后DCE-MRI的半定量分析研究较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Aim was to perform a systematic review to evaluate the clinical value of dynamic contrast-enhanced (DCE) MRI in rectal cancer.
METHODS AND MATERIALS: A systematic search was performed on Pubmed, Embase and the Cochrane library. Studies that evaluated DCE-MRI for tumour aggressiveness, primary staging and restaging after chemoradiation (CRT) were included. Information on population, DCE technique, DCE parameters and outcome (angiogenesis, staging and response) were extracted.
RESULTS: 19 studies were identified; 10 evaluated quantitative analyses, 6 semiquantitative analyses and 3 evaluated both. 8 studies evaluated correlation between DCE-parameters and angiogenesis or tumour aggressiveness, 11 studies evaluated response prediction pre- and post-CRT. Semiquantitative washin parameters showed a significantly positive correlation with angiogenesis, while for quantitative analyses conflicting results were found. Conflicting results were also reported for the correlation between DCE parameters and tumour aggressiveness: both higher and lower vascularity in more aggressive tumours are reported, while some studies report no correlation. Six studies showed a predictive value of Ktrans for response. A high Ktrans pre-CRT was significantly correlated with a complete/good response, but the reported pre-CRT Ktrans varied substantially (0.36-1.93). After CRT a reduction in Ktrans of 32%-36% was significantly associated with response. For semiquantitative analyses pre-CRT late slope was reported to be significantly lower in good responders, however only few studies exist on semiquantitative analyses of post-CRT DCE-MRI.
CONCLUSION: DCE-MRI in rectal cancer is promising mainly for prediction and assessment of response to CRT, where a high pre-CRT Ktrans and a decrease in Ktrans are significantly predictive for response.
引用
- Dijkhoff RAP, Beets-Tan RGH, Lambregts DMJ, et al. Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review. Eur J Radiol. 2017. PMID: 28987662. doi:10.1016/j.ejrad.2017.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。